Get to know us

Investing in the Future of Healthcare

Invidia Capital Management

Invidia Capital Management is a healthcare-focused investment firm headquartered in New York, dedicated to middle-market buyouts across North America. Invidia invests exclusively in healthcare, a sector that is both defensive and undergoing profound transformation. The firm aims to bring a differentiated perspective to healthcare investing —applying mega-cap investing discipline and rigor to the middle market, a segment with a long track record of outperformance. Invidia’s partners, senior advisors, and extended network bring decades of domain experience and pattern recognition to a sector defined by complexity. The firm partners with high-quality companies and exceptional teams with the goal of improving patient outcomes while driving cost efficiencies. Invidia’s mission is to create durable, long-term value across the healthcare ecosystem—for patients, providers, and payors alike.

Investment Focus

Invidia invests exclusively in healthcare, a sector undergoing profound transformation and growth.
We concentrate on four subsectors with long-term structural tailwinds:

Supporting R&D Innovation:

  • Pharma Services
  • Medtech Services
  • CRO, CDMO and Contract Mfg.
  • Devices, Diagnostics, & Tools
  • Regulatory Consulting

Tech-Enabled Services:

  • HCIT
  • Payor & Provider Tech
  • Data Access
  • Interoperability
  • Virtual Care

Delivery Transformation:

  • Pharmacy Services
  • Multi-Site Providers
  • Efficiency Technology
  • Home Care Enablement

Consumer-Oriented Healthcare:

  • Retail Healthcare
  • Primary Care
  • Animal Health
  • Women’s Health

An Invidia Deal – Target Company Criteria

We seek businesses that are well-positioned to thrive in dynamic markets and where our platform can unlock meaningful value. Generally, ideal partners demonstrate:

  • Approximately $15–50 million EBITDA
    Solid secular tailwinds and durable end-market demand
  • Proven business models with limited binary risk
  • Multiple avenues for organic growth
  • Diverse exit pathways
  • Paths to leverage Invidia’s expertise, network, and operating resources

Value Creation Approach

At Invidia, we aim to take an active, hands-on role in value creation. Our team seeks to works side by side with management to unlock potential through, among other methods:

  • Team & Talent Investments and Alignment
  • Technology Transformation & Data Integration
  • Go-to-Market Strategy & Commercial Reach
  • Value-Add M&A

Our Core Values

Invidia is building a world-class investment firm grounded in a robust culture and core values,
dedicated to benefitting all constituencies in healthcare: patients, providers, and payors.

Excellence & Innovation

We focus on delivering excellence and innovation in all aspects of healthcare investing, from identifying promising opportunities to optimizing portfolio company performance.
We embrace creativity and forward-thinking solutions to address complex healthcare challenges.

Holistic Perspective

We adopt and seek to implement a wide step disciplined approach to healthcare investing. Recognizing the interconnectedness of healthcare with social and economic issues, we understand the human impact of these decisions. We prioritize empathy and compassion toward patients, understanding their needs and challenges as central to our mission.

Collaboration and Partnership

We foster collaborative partnerships with portfolio companies, healthcare providers, sponsors, LPs, and other industry stakeholders. Invidia recognizes that meaningful change and innovation often result from collective efforts and shared experience. 

Adaptability and Resilience

We remain adaptable and resilient in the face of evolving healthcare landscapes, market dynamics, and regulatory changes and we seek to embrace agility and flexibility to seize opportunities and navigate challenges effectively.

Long-Term Value Creation

We focus on creating long-term value for all stakeholders, including investors, portfolio companies, employees, and communities.